Investing Profile

Daniel Estes

InvestorVC

General Partner at Frazier Life Sciences

Your Intro Paths to Daniel Estes

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Daniel is a member of

Stanford University Network

1332 CONNECTIONS

Mckinsey & Company Network

664 CONNECTIONS

University of Michigan Network

261 CONNECTIONS

Find Daniel Estes on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Daniel Estes is on these Sector & Stage Rankings

Daniel Estes's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Sidewinder Therapeutics	Series BApr 2026$140M	$140M
Co-investors: John Hamer (Financial Services, Financial Technology, and Business Services), Michal Silverberg (Novartis Venture Fund)
Iolyx Therapeutics	Series BDec 2025$15M	$15M
Co-investors: Chris Sklarin (Castor Ventures)
Hillstar Bio	Series AMar 2025$67M	$67M
Callio Therapeutics	Series AMar 2025$190M	$190M
Co-investors: Brian Matesic (Norwest Venture Partners), Vincent Ossipow (Omega Funds)
Alesta Therapeutics	Series AJan 2025$67M	$67M
Co-investors: Laura Brass (MPM BioImpact)
Bluejay Therapeutics	Series CMay 2024$180M	$220M
Co-investors: Nancy Hong (San Diego Symphony)
Sudo Biosciences	Series BFeb 2024$30M Series BDec 2023$120M Series ASep 2022$37M	$180M
Co-investors: Christopher Gagliardi (Sanofi Ventures), Shinichiro Fuse (TPG Biotech)
Radionetics Oncology	SeedOct 2021$30M	$83M
Co-investors: Eric Shiozaki (Revelation Partners), David Allison (Westlake Village BioPartners)

Daniel Estes's Experience

Biotechnology Consultant Mckinsey & CompanyPresent

Co-Founder Radionetics Oncology, Inc.Present

General Partner Frazier Life SciencesPresent

Daniel Estes's Education

Stanford University BS Electrical Engineering

University of Michigan PhD Biomedical Engineering

Investors who invest with Daniel Estes

Scouts & Angels Affiliated With Daniel Estes